Recherche de modèles d'affaires durables

Les nouveaux défis suscités par les changements sans précédent dans l'industrie sont tels que l'on en vient à se poser des questions sur la viabilité du modèle d'affaires: est-ce du déjà-vu pour le secteur ou la crise actuelle est-elle vraiment différente?

2008: The year of the great breakthrough?

The year 2007 was excellent from the financing perspective. New investors pumped more than CHF 885 million into biotechnology, exceeding the previous record from the year 2006.

Historic Advances

The global biotech sector reported a record number of products in the pipeline and record inflows of risk capital in 2006. Switzerland, for its part, is the leading biotech location in the world in terms of size and number of inhabitants. And the future of the Swiss biotech industry remains rosy.

A Prime Example of a Competitive Business Location

Switzerland is the location of choice for over 137 biotech companies and 81 biotech industry suppliers. In 2006 the Swiss biotech sector generated global revenue of over CHF 6 billion and employed over 14,000 people. In terms of size and number of inhabitants, Switzerland is the leading biotech location in the world.

Positive effects on the Swiss economy

Switzerland is the leading biotech location in the world in terms of size and number of inhabitants. Experiencing another successful year in 2006, the Swiss biotechnology industry nevertheless faced some unexpected market developments.